The need for rigorous evidence on medication use in preterm infants: is it time for a neonatal rule?

JAMA. 2012 Oct 10;308(14):1435-6. doi: 10.1001/jama.2012.12883.

Authors

Jonathan M Davis¹, Edward M Connor, Alastair J J Wood

Affiliation

¹ Department of Pediatrics, Floating Hospital for Children at Tufts Medical Center, Boston, Massachusetts 02111, USA. jdavis@tuftsmedicalcenter.org

PMID: 23047355
DOI: 10.1001/jama.2012.12883

No abstract available

Publication types

Research Support, N.I.H., Extramural

MeSH terms

Drug Discovery*
Drug Industry
Evidence-Based Practice*
Humans
Infant, Newborn
Infant, Newborn, Diseases / drug therapy
Infant, Premature*
Intensive Care Units, Neonatal
Off-Label Use
Premature Birth
Randomized Controlled Trials as Topic
United States
United States Food and Drug Administration